Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating donor stem cell transplant for adults with acute myeloid leukemia in remission has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Erythroid Leukemia
• Monocytic Leukemia

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Adult Acute Erythroid Leukemia, Adult Acute Monoblastic and Acute Monocytic Leukemia | Phase 2 | Status: WITHDRAWN